Open AccessBlocking Egfr with Nimotuzumab: A Novel Strategy for Covid-19 Treatment
Author(s) -
Henrry Diaz Londres,
Jorge Jiménez Armada,
Aray Hernández Martínez,
Anselmo Abdo Cuza,
Yamilka Hernández Sánchez,
Aylin Granado Rodríguez,
Sarahy Sepúlveda Figueroa,
Egda M Llanez Gregorich,
Mery L Torres Lahera,
Francisco Gómez Peire,
Teresita Montero-González,
Yaneth Zamora González,
Ana Laura Añé-Kourí,
Addys González Palomo,
Mayelin Troche Concepción,
Loipa Medel Pérez,
Patricia Lorenzo-Luaces,
Daymys Estévez Iglesias,
Danay Saavedra,
Mayra Ramos,
Tania Crombet
Publication year - 2022
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2022-0027
Subject(s) - nimotuzumab , medicine , diabetes mellitus , epidermal growth factor receptor , cancer , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom